Dr. Reddy's Laboratories Limited (DRREDDY.NS)
INR 1321.2
(3.59%)
INR 1321.2
(3.59%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 20.02 Billion INR | 48.6% |
| 2022 | 13.47 Billion INR | -60.2% |
| 2021 | 33.84 Billion INR | 11.67% |
| 2020 | 30.3 Billion INR | 37.13% |
| 2019 | 22.1 Billion INR | -42.41% |
| 2018 | 38.38 Billion INR | -24.32% |
| 2017 | 50.71 Billion INR | 3.11% |
| 2016 | 49.18 Billion INR | 46.76% |
| 2015 | 33.51 Billion INR | -22.29% |
| 2014 | 43.12 Billion INR | -3.61% |
| 2013 | 44.74 Billion INR | -87.83% |
| 2012 | 367.59 Billion INR | 1041.25% |
| 2011 | 32.21 Billion INR | 36.38% |
| 2010 | 23.61 Billion INR | 60.71% |
| 2009 | 14.69 Billion INR | -25.41% |
| 2008 | 19.7 Billion INR | 0.82% |
| 2007 | 19.54 Billion INR | -21.24% |
| 2006 | 24.81 Billion INR | -20.15% |
| 2005 | 31.07 Billion INR | 999.07% |
| 2004 | 2.82 Billion INR | 459.42% |
| 2003 | 505.42 Million INR | 53.11% |
| 2002 | 330.09 Million INR | 116.3% |
| 2001 | 152.61 Million INR | -96.12% |
| 2000 | 3.93 Billion INR | 0.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q2 | 48.54 Billion INR | 58.24% |
| 2024 Q1 | 30.67 Billion INR | 53.22% |
| 2023 Q3 | 19.85 Billion INR | 50.05% |
| 2023 Q2 | 13.23 Billion INR | 5.67% |
| 2023 FY | 20.02 Billion INR | 48.6% |
| 2023 Q4 | 20.02 Billion INR | 0.85% |
| 2023 Q1 | 12.52 Billion INR | -7.07% |
| 2022 Q4 | 13.47 Billion INR | -23.73% |
| 2022 FY | 13.47 Billion INR | -60.2% |
| 2022 Q3 | 17.66 Billion INR | 2.16% |
| 2022 Q1 | 24.66 Billion INR | -27.12% |
| 2022 Q2 | 17.28 Billion INR | -29.91% |
| 2021 Q2 | 30.27 Billion INR | -9.29% |
| 2021 FY | 33.84 Billion INR | 11.67% |
| 2021 Q1 | 33.37 Billion INR | 10.11% |
| 2021 Q4 | 33.84 Billion INR | 20.17% |
| 2021 Q3 | 28.16 Billion INR | -6.97% |
| 2020 Q3 | 20.44 Billion INR | -25.47% |
| 2020 Q4 | 30.3 Billion INR | 48.26% |
| 2020 FY | 30.3 Billion INR | 37.13% |
| 2020 Q1 | 31.58 Billion INR | 42.89% |
| 2020 Q2 | 27.42 Billion INR | -13.15% |
| 2019 Q2 | 31.54 Billion INR | -8.27% |
| 2019 Q3 | 16.32 Billion INR | -48.26% |
| 2019 FY | 22.1 Billion INR | -42.41% |
| 2019 Q4 | 22.1 Billion INR | 35.43% |
| 2019 Q1 | 34.38 Billion INR | -10.4% |
| 2018 Q2 | 55.52 Billion INR | 2.3% |
| 2018 Q1 | 54.27 Billion INR | 7.02% |
| 2018 Q4 | 38.38 Billion INR | -12.44% |
| 2018 Q3 | 43.83 Billion INR | -21.05% |
| 2018 FY | 38.38 Billion INR | -24.32% |
| 2017 Q4 | 50.71 Billion INR | -7.64% |
| 2017 FY | 50.71 Billion INR | 3.11% |
| 2017 Q3 | 54.91 Billion INR | 2.32% |
| 2017 Q2 | 53.66 Billion INR | 6.35% |
| 2017 Q1 | 50.46 Billion INR | 2.6% |
| 2016 Q3 | 57.99 Billion INR | -4.1% |
| 2016 Q2 | 60.48 Billion INR | 60.71% |
| 2016 Q4 | 49.18 Billion INR | -15.2% |
| 2016 Q1 | 37.63 Billion INR | 12.29% |
| 2016 FY | 49.18 Billion INR | 46.76% |
| 2015 Q2 | 37.07 Billion INR | -10.45% |
| 2015 Q4 | 33.51 Billion INR | -0.85% |
| 2015 Q1 | 41.4 Billion INR | -4.0% |
| 2015 FY | 33.51 Billion INR | -22.29% |
| 2015 Q3 | 33.8 Billion INR | -8.83% |
| 2014 FY | 43.12 Billion INR | -3.61% |
| 2014 Q3 | 39.65 Billion INR | 2.06% |
| 2014 Q2 | 38.85 Billion INR | -7.09% |
| 2014 Q1 | 41.81 Billion INR | -6.54% |
| 2014 Q4 | 43.12 Billion INR | 8.75% |
| 2013 Q3 | 49.34 Billion INR | 0.25% |
| 2013 Q1 | 43.99 Billion INR | -88.03% |
| 2013 Q4 | 44.74 Billion INR | -9.33% |
| 2013 Q2 | 49.22 Billion INR | 11.89% |
| 2013 FY | 44.74 Billion INR | -87.83% |
| 2012 FY | 367.59 Billion INR | 1041.25% |
| 2012 Q4 | 367.59 Billion INR | 898.23% |
| 2012 Q2 | 34.9 Billion INR | -1.49% |
| 2012 Q1 | 35.43 Billion INR | 10.0% |
| 2012 Q3 | 36.82 Billion INR | 5.51% |
| 2011 FY | 32.21 Billion INR | 36.38% |
| 2011 Q4 | 32.21 Billion INR | -16.34% |
| 2011 Q3 | 38.5 Billion INR | 23.0% |
| 2011 Q2 | 31.3 Billion INR | 30.76% |
| 2011 Q1 | 23.94 Billion INR | 1.37% |
| 2010 Q1 | 13.87 Billion INR | -5.6% |
| 2010 Q3 | 13.8 Billion INR | -4.73% |
| 2010 Q4 | 23.61 Billion INR | 71.04% |
| 2010 FY | 23.61 Billion INR | 60.71% |
| 2010 Q2 | 14.49 Billion INR | 4.48% |
| 2009 Q3 | 12.67 Billion INR | -13.6% |
| 2009 Q1 | 16.1 Billion INR | -18.24% |
| 2009 Q4 | 14.69 Billion INR | 15.96% |
| 2009 Q2 | 14.66 Billion INR | -8.94% |
| 2009 FY | 14.69 Billion INR | -25.41% |
| 2008 FY | 19.7 Billion INR | 0.82% |
| 2008 Q4 | 19.7 Billion INR | -11.51% |
| 2008 Q1 | 18.85 Billion INR | -3.53% |
| 2008 Q2 | 22.18 Billion INR | 17.71% |
| 2008 Q3 | 22.26 Billion INR | 0.34% |
| 2007 Q4 | 19.54 Billion INR | 14.36% |
| 2007 Q3 | 17.08 Billion INR | 4.71% |
| 2007 Q2 | 16.31 Billion INR | 6.54% |
| 2007 Q1 | 15.31 Billion INR | -38.27% |
| 2007 FY | 19.54 Billion INR | -21.24% |
| 2006 Q3 | 27.93 Billion INR | -13.39% |
| 2006 Q4 | 24.81 Billion INR | -11.16% |
| 2006 Q1 | 33.34 Billion INR | 7.31% |
| 2006 FY | 24.81 Billion INR | -20.15% |
| 2006 Q2 | 32.25 Billion INR | -3.29% |
| 2005 FY | 31.07 Billion INR | 999.07% |
| 2005 Q3 | 3.85 Billion INR | -6.77% |
| 2005 Q4 | 31.07 Billion INR | 705.49% |
| 2005 Q1 | 3.94 Billion INR | 39.61% |
| 2005 Q2 | 4.13 Billion INR | 4.83% |
| 2004 Q4 | 2.82 Billion INR | 38.22% |
| 2004 FY | 2.82 Billion INR | 459.42% |
| 2004 Q1 | 2.37 Billion INR | 369.66% |
| 2004 Q3 | 2.04 Billion INR | 39.51% |
| 2004 Q2 | 1.46 Billion INR | -38.23% |
| 2003 Q1 | 181.76 Million INR | -44.93% |
| 2003 Q4 | 505.42 Million INR | 171.49% |
| 2003 Q2 | 180.13 Million INR | -0.9% |
| 2003 Q3 | 186.16 Million INR | 3.35% |
| 2003 FY | 505.42 Million INR | 53.11% |
| 2002 FY | 330.09 Million INR | 116.3% |
| 2002 Q3 | 190.45 Million INR | 0.32% |
| 2002 Q4 | 330.09 Million INR | 73.32% |
| 2002 Q1 | 181.68 Million INR | 19.05% |
| 2002 Q2 | 189.85 Million INR | 4.5% |
| 2001 FY | 152.61 Million INR | -96.12% |
| 2001 Q1 | 529.46 Million INR | 0.0% |
| 2001 Q2 | 363.22 Million INR | -31.4% |
| 2001 Q4 | 152.61 Million INR | -22.95% |
| 2001 Q3 | 198.07 Million INR | -45.47% |
| 2000 FY | 3.93 Billion INR | 0.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Sigachi Industries Limited | 1.43 Billion INR | -1299.494% |
| Ind-Swift Limited | 10.13 Billion INR | -97.437% |
| Bajaj HealthCare Limited | 3.32 Billion INR | -501.519% |
| Sakar Healthcare Limited | 793.51 Million INR | -2422.948% |
| Aurobindo Pharma Limited | 66.47 Billion INR | 69.884% |
| Innova Captab Limited | 2.45 Billion INR | -716.796% |
| Divi's Laboratories Limited | 30 Million INR | -66633.333% |
| AstraZeneca Pharma India Limited | 45.98 Million INR | -43438.776% |
| Morepen Laboratories Limited | 289.99 Million INR | -6803.639% |
| Mankind Pharma Limited | 2.07 Billion INR | -866.345% |
| Sequent Scientific Limited | 4.87 Billion INR | -310.504% |
| Wanbury Limited | 1.16 Billion INR | -1618.682% |
| Laurus Labs Limited | 25.77 Billion INR | 22.325% |
| Nectar Lifesciences Limited | 6.35 Billion INR | -215.01% |
| Glenmark Life Sciences Limited | 171.48 Million INR | -11574.831% |
| Alembic Limited | 91.5 Million INR | -21779.781% |
| Hikal Limited | 8.17 Billion INR | -144.869% |
| Alembic Pharmaceuticals Limited | 5.13 Billion INR | -290.132% |
| Neuland Laboratories Limited | 953.89 Million INR | -1998.761% |
| J. B. Chemicals & Pharmaceuticals Limited | 3.77 Billion INR | -430.106% |
| Glenmark Pharmaceuticals Limited | 12.3 Billion INR | -62.641% |
| IOL Chemicals and Pharmaceuticals Limited | 327.6 Million INR | -6011.111% |
| Themis Medicare Limited | 957.92 Million INR | -1989.941% |
| RPG Life Sciences Limited | - INR | -Infinity% |
| Zydus Lifesciences Limited | 8.04 Billion INR | -148.943% |
| Lupin Limited | 29.21 Billion INR | 31.48% |
| Amrutanjan Health Care Limited | 17.28 Million INR | -115736.371% |
| Wockhardt Limited | 23.56 Billion INR | 15.025% |
| Vaishali Pharma Limited | 134.91 Million INR | -14738.643% |
| Aarti Pharmalabs Limited | 2.85 Billion INR | -601.84% |
| Jagsonpal Pharmaceuticals Limited | 89.41 Million INR | -22291.231% |
| Jubilant Pharmova Limited | 36.64 Billion INR | 45.36% |
| FDC Limited | 205.18 Million INR | -9657.049% |
| Kilitch Drugs (India) Limited | 316.46 Million INR | -6226.134% |
| Eris Lifesciences Limited | 27.81 Billion INR | 28.018% |
| Venus Remedies Limited | 413.3 Million INR | -4743.939% |
| ZIM Laboratories Limited | 1.08 Billion INR | -1739.661% |
| Bliss GVS Pharma Limited | 998.4 Million INR | -1905.206% |
| Par Drugs and Chemicals Limited | - INR | -Infinity% |
| Caplin Point Laboratories Limited | 19.7 Million INR | -101524.365% |
| Shilpa Medicare Limited | 9.37 Billion INR | -113.572% |
| Albert David Limited | 33.24 Million INR | -60125.018% |
| Ajanta Pharma Limited | 352.8 Million INR | -5574.603% |
| Hester Biosciences Limited | 2.44 Billion INR | -719.223% |
| Suven Pharmaceuticals Limited | 649.96 Million INR | -2980.171% |
| Solara Active Pharma Sciences Limited | 10.11 Billion INR | -97.924% |
| Gufic Biosciences Limited | 3.32 Billion INR | -501.353% |
| Windlas Biotech Limited | 36.41 Million INR | -54884.894% |
| Procter & Gamble Health Limited | 95.6 Million INR | -20841.423% |
| Aarey Drugs & Pharmaceuticals Limited | 313.52 Million INR | -6285.495% |
| Mangalam Drugs & Organics Limited | 984.92 Million INR | -1932.642% |
| Granules India Limited | 13.15 Billion INR | -52.236% |
| Aarti Drugs Limited | 5.64 Billion INR | -254.795% |
| Bal Pharma Limited | 1.39 Billion INR | -1333.6% |
| Alkem Laboratories Limited | 14.18 Billion INR | -41.144% |
| Sun Pharmaceutical Industries Limited | 32.73 Billion INR | 38.845% |
| Lincoln Pharmaceuticals Limited | 10.66 Million INR | -187564.042% |
| Medicamen Biotech Limited | 308.17 Million INR | -6396.372% |
| Unichem Laboratories Limited | 2.47 Billion INR | -708.842% |
| Bafna Pharmaceuticals Limited | 243.89 Million INR | -8108.518% |
| Biofil Chemicals and Pharmaceuticals Limited | 4.38 Million INR | -456040.351% |
| Valiant Laboratories Limited | 767.08 Million INR | -2509.884% |
| Orchid Pharma Limited | 1.35 Billion INR | -1380.982% |
| Medico Remedies Limited | 80.5 Million INR | -24768.33% |
| Ind-Swift Laboratories Limited | 166.21 Million INR | -11944.569% |
| Ipca Laboratories Limited | 14.38 Billion INR | -39.186% |
| Brooks Laboratories Limited | 56.41 Million INR | -35384.5% |
| Syncom Formulations (India) Limited | 724.86 Million INR | -2661.89% |
| Piramal Enterprises Limited | 535.85 Billion INR | 96.264% |
| Torrent Pharmaceuticals Limited | 40.22 Billion INR | 50.224% |
| NATCO Pharma Limited | 3.71 Billion INR | -439.332% |
| Suven Life Sciences Limited | 7.09 Million INR | -281991.024% |
| Krebs Biochemicals & Industries Limited | 1.93 Billion INR | -935.002% |
| Strides Pharma Science Limited | 25.16 Billion INR | 20.457% |
| Indoco Remedies Limited | 6.71 Billion INR | -197.934% |
| Alpa Laboratories Limited | 52.46 Million INR | -38058.773% |
| Lasa Supergenerics Limited | 220.76 Million INR | -8968.59% |
| Sun Pharma Advanced Research Company Limited | 611.5 Million INR | -3173.917% |